Omega Fund Management, LLC
Position in BBOT — BridgeBio Oncology Therapeutics, Inc.
CIK 1637359
Boston, MA
Position in BBOT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$29,442,465
-$11,744,090 QoQ
Shares Held
3,289,661
0.0% QoQ
Ownership
4.11%
of shares outstanding
% of Portfolio
18.05%
of 13F equity value
Holder Rank
#3
of 67 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBOT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Omega Fund Management, LLC holds $129,582,182 across 8 Biotechnology names. BBOT ranks #3 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCAX |
Bicara Therapeutics Inc.
|
2,392,150 | $47,579,863 | |
| 2 | NUVB |
Nuvation Bio Inc.
|
8,081,089 | $34,667,871 | |
| 3 | BBOT |
BridgeBio Oncology Therapeutics, Inc.
This page
|
3,289,661 | $29,442,465 | |
| 4 | ENGN |
enGene Therapeutics Inc.
|
876,357 | $5,967,991 | |
| 5 | ALMS |
Alumis Inc.
|
241,255 | $5,314,847 | |
| 6 | SANA |
Sana Biotechnology, Inc.
|
843,750 | $2,430,000 | |
| 7 | IMA |
ImageneBio, Inc.
|
455,361 | $2,276,805 | |
| 8 | REPL |
Replimune Group, Inc.
|
248,672 | $1,902,340 |
All Filings in BBOT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29,442,465 | 3,289,661 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $41,186,555 | 3,289,661 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $38,094,274 | 3,289,661 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||